GSK Plc
NYSE: GSK
$33.60
+$0.17 (+0.5%)
Closing Price on December 20, 2024
GSK Articles
A new Jefferies research report features the firm's top pharmaceutical stock picks in order of preference, and AbbVie stays in the top position.
Published:
Last Updated:
At 24/7 Wall St. we are constantly on the lookout for stocks that pay good dividends, are not horribly overbought and are rated reasonably high by some of the top firms we cover.
Published:
Last Updated:
These three safe and relatively defensive stocks that pay solid dividends could be outstanding choices for income accounts looking to take utility gains and roll into something with better upside...
Published:
Last Updated:
Though these clearly are stocks for more aggressive accounts, the total return potential is outstanding, and all of them do very well in their respective sectors.
Published:
Last Updated:
Viagra, the wildly successful erectile dysfunction pill, faces challenges from a generic version that will launch next year.
Published:
Last Updated:
The stock market has recovered a majority of its post-Brexit losses, with the Dow’s 900+ point drop from last Thursday to being less than 100 points down. Investors have different reasons each...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday morning include Baidu, Caterpillar, GE, Honeywell, Kimberly-Clark, Schlumberger and Southern Energy.
Published:
Last Updated:
Ionis Pharmaceuticals made waves in the market on Thursday following a business update on its IONIS-TTR program.
Published:
Last Updated:
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
Published:
Last Updated:
Looking outside the United States can sometimes reveal other companies that offer the same stability, with the added benefit of global diversification if a U.S.-specific problem develops.
Published:
Last Updated:
24/7 Wall St. screened the Merrill Lynch research universe for large-cap blue chip stocks that paid a 5% dividend.
Published:
Last Updated:
Tuesday's top analyst upgrades, downgrades and initiations include Bluebird Bio, Boston Beer, Etsy, Gilead Sciences, Pfizer, PMC-Sierra and Valeant Pharmaceuticals.
Published:
Last Updated:
Friday's top analyst upgrades, downgrades and initiations include Charles Schwab, 3D Systems, Stratasys, Groupon, Lifepoint Health and E*Trade.
Published:
ThinkstockAny time that you hear about new drugs and medical treatments, they tend to be around ongoing treatments rather than cures. And when it comes to AIDS and HIV, the past has been cruel...
Published:
Tuesday's top analyst upgrades and downgrades from 24/7 Wall St. include Cisco Systems, Dreamworks Animation, Lululemon Athletica, Schlumberger and Verizon Communications.
Published: